Thornberry Nancy
CIK 0001797826
Director
Filings
14
Latest May 5, 2026
Issuers covered
3
Showing
14 of 14
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -20.9% | -20.9% | -20.9% | -20.9% |
| 90 days | 1 | 100% | +5.8% | +5.8% | +5.8% | +5.8% |
| 180 days | 1 | 100% | +21.7% | +21.7% | +21.7% | +21.7% |
| 365 days | 1 | 100% | +43.4% | +43.4% | +43.4% | +43.4% |
Issuers
Companies where Thornberry Nancy has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | 5 | Jun 5, 2025 |
| SDGR | Schrodinger, Inc. | 5 | Jun 20, 2025 |
| VRTX | Vertex Pharmaceuticals Inc / Ma | 4 | May 5, 2026 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|